Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response.
Biochim Biophys Acta
; 1866(1): 87-105, 2016 08.
Article
in En
| MEDLINE
| ID: mdl-27373814
ABSTRACT
Increased glycolysis is the main source of energy supply in cancer cells that use this metabolic pathway for ATP generation. Altered energy metabolism is a biochemical fingerprint of cancer cells that represents one of the "hallmarks of cancer". The immune system can prevent tumour growth by eliminating cancer cells but this editing process ultimately results in poorly immunogenic cells remaining allowing for unchallenged tumour growth. In this review we look at the glycolysis pathway as a target for cancer treatments. We also examine the interplay between the glycolysis modulation and the immune response as an anti-cancer therapy.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glycolysis
/
Immunity, Cellular
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Biochim Biophys Acta
Year:
2016
Document type:
Article
Affiliation country:
Ireland